Biography

Dr. Linawati Hananta completed her Bachelor of Medicine at Unika Atma Jaya in 1995 and then pursued her specialization (Sp1) at the University of Indonesia, earning the degree in 2008. She also obtained her Doctorate from Gadjah Mada University in 2018. With expertise in Pharmacology and Pharmacogenetics, Dr. Linawati teaches various courses related to Pharmacogenetics & Nutrigenomics, Pharmacogenomics-Pharmacogenetics, as well as Genetics, Hematology, and Humanities. She is committed to providing a deep understanding of various body systems and important aspects of medicine and health. As a researcher, Dr. Linawati focuses on public health, pharmacogenomics, and nutrition. In her intriguing publication, "The Association of Mobile Screen Time and Elevated Blood Pressure During the COVID-19 Pandemic," she explores the impact of increased mobile screen use during the pandemic on blood pressure. She also discusses the role of pharmacogenomics in treatment in her publication "Pharmacogenomic Role in Cytochrome P450 Enzymes-Mediated Metabolism for Drug Therapy," which provides insights for tailoring drug therapy based on patients' genetic profiles. Other research includes analyzing vitamin D levels in COVID-19 vaccine recipients and the influence of lactoferrin on liver disease. Lastly, she examines how sleep quality affects the humoral response in recipients of the Sinovac vaccine. With an innovative research approach, Dr. Linawati continues to strive to enhance the understanding of factors affecting public health.

Education

Dr. Linawati Hananta completed her Bachelor of Medicine at Unika Atma Jaya in 1995. She then pursued her specialization (Sp1) at the University of Indonesia, successfully earning the degree in 2008. Dr. Linawati also obtained her Doctorate from Gadjah Mada University in 2018.

Expertise

Dr. Linawati has expertise in Pharmacology and Pharmacogenetics, focusing on drug interactions and individual responses to therapy based on genetic factors.

Teaching

As an educator, Dr. Linawati teaches courses related to Pharmacogenetics & Nutrigenomics, as well as Pharmacogenomics-Pharmacogenetics. She also teaches Genetics I, Hematology, and Humanities. In addition, Dr. Linawati provides in-depth understanding of Basic Biomedical Science through six levels of courses, as well as Medical Emergencies, Mental and Behavioral Health, Pathology Concepts (1, 2, and 3), Palliative Care, and various body systems such as the Endocrine & Metabolism System, Gastrointestinal System, Neuromusculoskeletal System, and Respiratory System. Through these courses, Dr. Linawati is committed to equipping students with comprehensive knowledge in the field of medicine and health.

Recent Publications

Dr. Linawati Hananta Sp.FK is a doctor and researcher focused on public health, pharmacogenomics, and nutrition. Her research explores the relationship between lifestyle, drug metabolism, and immune response, and their impact on individual health.

One of her notable publications, "The Association of Mobile Screen Time and Elevated Blood Pressure During the COVID-19 Pandemic," investigates the impact of increased mobile screen use during the COVID-19 pandemic on blood pressure. The findings from this study could help understand emerging health risk factors due to behavioral changes during the pandemic.

In the publication "Pharmacogenomic Role in Cytochrome P450 Enzymes-Mediated Metabolism for Drug Therapy," Dr. Linawati discusses the role of pharmacogenomics in drug therapy, particularly how genetic variations affect drug metabolism mediated by cytochrome P450 enzymes. This research provides valuable insights for clinical practice in tailoring drug therapy based on patients' genetic profiles.

Additionally, in her publication "Serum Vitamin D Levels by Gender in COVID-19 Vaccine Recipients at FKIK UAJ," Dr. Linawati analyzes vitamin D levels in individuals who received the COVID-19 vaccine, offering critical information on the relationship between nutritional status and vaccine efficacy.

Dr. Linawati also investigated the effects of lactoferrin on histopathological changes in hyperlipidemia-induced fatty liver in rats, in the study titled "Role of Lactoferrin on the Histopathological Changes of Hyperlipidemic-Induced Fatty Liver in Rats." This research highlights the potential of lactoferrin as a nutritional intervention in managing liver disease.

Lastly, in her publication "Sleep Quality Affects Humoral Response in Recipients of Two-Dose Sinovac Vaccines," Dr. Linawati explores how sleep quality affects the humoral response in recipients of the Sinovac vaccine. The findings underscore the importance of lifestyle factors, such as sleep quality, in optimizing vaccine effectiveness.

With her innovative and applied research approach, Dr. Linawati Hananta Sp.FK is committed to enhancing understanding of the factors influencing public health and well-being.